Vor Biopharma Inc. (VOR) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 28K | 0 | 0 | 0 | 0 | 865K | 0 | 900K | 943K | 892K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -28K | 0 | 0 | 0 | 0 | -865K | 0 | -900K | -943K | -892K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | 100% | 100% | 3.03% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 35.13M | 35.96M | 28.11M | 274.28M | 33.29M | 30.45M | 28.51M | 28.14M | 31.38M | 27.23M | 35.32M | 32.17M | 30.42M | 24.73M | 24.1M | 21.79M | 22.8M | 18.31M | 18.6M | 18.38M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 17.54M | 16.77M | 14.42M | 2.4M | 6.59M | 5.1M | 6.7M | 6.31M | 7.06M | 6.33M | 7.71M | 8.28M | 8.51M | 7.66M | 7.23M | 6.46M | 7.52M | 5.61M | 5.68M | 5.41M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 17.59M | 19.19M | 14.14M | 261.5M | 26.7M | 25.35M | 21.82M | 21.82M | 24.32M | 20.9M | 27.61M | 23.9M | 21.91M | 17.06M | 16.88M | 15.33M | 15.28M | 12.69M | 12.93M | 12.97M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | -451K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -35.16M | -35.96M | -28.11M | -274.28M | -33.29M | -31.31M | -28.51M | -29.04M | -32.33M | -28.12M | -35.32M | -32.17M | -30.42M | -24.73M | -24.1M | -21.79M | -22.8M | -18.31M | -18.6M | -18.38M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -5.61% | -14.85% | 1.42% | -844.67% | -2.99% | -11.33% | 19.26% | 9.76% | -6.26% | -13.75% | -46.53% | -47.64% | -33.43% | -35.07% | -29.56% | -18.56% | -66.06% | -16.87% | -57.84% | -128.61% |
| EBITDA | -35.13M | -35.94M | -28.11M | -272.25M | -32.47M | -30.45M | -27.66M | -28.17M | -31.38M | -27.23M | -34.42M | -31.3M | -29.59M | -24.09M | -23.21M | -19.91M | -22.37M | -17.91M | -18.23M | -18.03M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -8.21% | -18.04% | -1.6% | -866.58% | -3.45% | -11.8% | 19.64% | 10.02% | -6.08% | -13.03% | -48.32% | -57.26% | -32.23% | -34.52% | -27.33% | -10.43% | -66.73% | -16.15% | -57.23% | -127.17% |
| D&A (Non-Cash Add-back) | 28K | 23K | 2K | 2.04M | 825K | 865K | 851K | 869K | 943K | 892K | 893K | 870K | 837K | 632K | 892K | 1.89M | 426K | 395K | 374K | 354K |
| EBIT | -35.16M | -35.96M | -812.68M | -243.55M | -33.29M | -30.71M | -28.51M | -29.04M | -32.33M | -26.26M | -35.32M | -32.17M | -30.42M | -24.73M | -24.1M | -21.79M | -22.8M | -18.31M | -18.6M | -18.38M |
| Net Interest Income | 3.94M | 2.79M | 1.73M | 537K | 805K | 599K | 954K | 1.2M | 1.52M | 1.86M | 2.13M | 2.19M | 1.99M | 815K | 313K | 133K | 63K | 54K | 48K | 10K |
| Interest Income | 3.94M | 2.79M | 1.73M | 537K | 805K | 599K | 954K | 1.2M | 1.52M | 1.86M | 2.13M | 2.19M | 1.99M | 815K | 313K | 133K | 63K | 54K | 48K | 10K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -184.43M | 1.76B | -784.58M | -1.3B | 805K | 599K | 954K | 1.2M | 1.52M | 1.86M | 2.13M | 2.19M | 1.99M | 815K | 313K | 133K | 63K | 54K | 48K | 10K |
| Pretax Income | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -575.94% | 5709.72% | -2848.89% | -5552.75% | -5.46% | -16.95% | 16.97% | 7.14% | -8.34% | -9.83% | -39.52% | -38.41% | -25.05% | -31% | -28.21% | -17.9% | -65.69% | -16.53% | -57.44% | -128.48% |
| Net Income (Continuing) | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -510.53 | 44.50 | -121.63 | -251.20 | -5.20 | -9.00 | -8.00 | -8.20 | -9.00 | -7.80 | -9.80 | -9.00 | -8.00 | -9.80 | -12.40 | -11.40 | -12.20 | -9.80 | -10.00 | -10.00 |
| EPS Growth % | -9717.88% | 594.44% | -1420.38% | -2963.41% | 42.22% | -15.38% | 18.37% | 8.89% | -12.5% | 20.41% | 20.97% | 21.05% | 34.43% | 0% | -24% | -14% | 1.61% | 30% | 48.45% | 24.24% |
| EPS (Basic) | -510.53 | 307.53 | -121.63 | -251.20 | -5.20 | -9.00 | -8.00 | -8.20 | -9.00 | -7.80 | -9.80 | -9.00 | -8.00 | -9.80 | -12.40 | -11.40 | -12.20 | -9.80 | -10.00 | -10.00 |
| Diluted Shares Outstanding | 430.12K | 9.87M | 6.68M | 6.26M | 6.24M | 3.44M | 3.42M | 3.41M | 3.4M | 3.39M | 3.38M | 3.35M | 3.31M | 2.32M | 1.9M | 1.87M | 1.86M | 1.85M | 1.85M | 1.84M |
| Basic Shares Outstanding | 430.12K | 9.87M | 6.68M | 6.26M | 6.24M | 3.44M | 3.42M | 3.41M | 3.4M | 3.39M | 3.38M | 3.35M | 3.31M | 2.32M | 1.9M | 1.87M | 1.86M | 1.85M | 1.85M | 1.84M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |